Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

Ainos, Inc. (NASDAQ:AIMD) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totaling 30,982 shares, a growth of 40.1% from the March 31st total of 22,109 shares. Approximately 0.5% of the company’s stock are short sold. Based on an average daily volume of 28,926 shares, the short-interest ratio is currently 1.1 days.

Insider Buying and Selling

In other Ainos news, major shareholder Carbon Nano Technology Taiwan sold 46,000 shares of the firm’s stock in a transaction dated Wednesday, January 28th. The shares were sold at an average price of $2.17, for a total transaction of $99,820.00. Following the transaction, the insider owned 989,925 shares of the company’s stock, valued at approximately $2,148,137.25. This trade represents a 4.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 9.79% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of AIMD. Two Sigma Investments LP purchased a new position in shares of Ainos in the 3rd quarter worth approximately $80,000. Renaissance Technologies LLC grew its position in shares of Ainos by 13.1% in the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after buying an additional 7,700 shares during the last quarter. DRW Securities LLC grew its position in Ainos by 272.6% during the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after purchasing an additional 48,439 shares during the last quarter. Finally, Mariner LLC purchased a new stake in Ainos during the 4th quarter worth approximately $37,000.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Ainos in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

Ainos Stock Up 4.0%

Shares of Ainos stock opened at $1.84 on Tuesday. The firm’s 50 day moving average price is $1.54 and its 200-day moving average price is $2.09. The company has a quick ratio of 0.78, a current ratio of 1.06 and a debt-to-equity ratio of 1.45. Ainos has a 52-week low of $1.26 and a 52-week high of $4.50. The company has a market cap of $13.38 million, a P/E ratio of -0.52 and a beta of 2.30.

Ainos (NASDAQ:AIMD) last issued its quarterly earnings data on Monday, March 30th. The company reported ($0.85) earnings per share (EPS) for the quarter. Ainos had a negative return on equity of 140.10% and a negative net margin of 11,912.10%.The firm had revenue of $0.01 million during the quarter.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.